Discovery of Imidazopyridine Derivatives as Highly Potent Respiratory Syncytial Virus Fusion Inhibitors

被引：71

作者：

Feng, Song ^{[1
]}

Hong, Di ^{[1
]}

Wang, Baoxia ^{[1
]}

Zheng, Xiufang ^{[1
]}

Miao, Kun ^{[1
]}

Wang, Lisha ^{[2
]}

Yun, Hongying ^{[1
]}

Gao, Lu ^{[3
]}

Zhao, Shuhai ^{[1
]}

Shen, Hong C. ^{[1
]}

机构：

[1] Roche Innovat Ctr Shanghai, Med Chem, Shanghai 201203, Peoples R China

[2] Roche Innovat Ctr Shanghai, Mol Design & Chem Biol, Shanghai 201203, Peoples R China

[3] Roche Innovat Ctr Shanghai, Infect Dis Pharmaceut Res & Early Dev, Shanghai 201203, Peoples R China

来源：

ACS MEDICINAL CHEMISTRY LETTERS | 2015年 / 6卷 / 03期

关键词：

Respiratory syncytial virus (RSV); virus; antiviral; fusion inhibitors; imidazopyridine; heterocycle; OPTIMIZATION; INFLUENZA; ENTRY;

D O I：

10.1021/acsmedchemlett.5b00008

中图分类号：

R914 [药物化学];

学科分类号：

100701 ;

摘要：

A series of imidazolepyridine derivatives were designed and synthesized according to the established docking studies. The imidazopyridine derivatives were found to have good potency and physical-chemical properties. Several highly potent compounds such as 8ji, 8j1, and 8jm were identified with single nanomolar activities. The most potent compound 8jrn showed an IC50 of 3 nM, lower nnicrosome clearance and no CYP inhibition. The profile of 8jrn appeared to be superior to BMS433771, and supported further optimization.

引用

页码：359 / 362

页数：4

共 50 条

[1] Accelerated Discovery of Potent Fusion Inhibitors for Respiratory Syncytial Virus
Pribut, Nicole
Kaiser, Thomas M.
Wilson, Robert J.
Jecs, Edgars
Dentmon, Zackery W.
Pelly, Stephen C.
Sharma, Savita
Bartsch, Perry W., III
Burger, Pieter B.
Hwang, Soyon S.
Le, Thalia
Sourimant, Julien
Yoon, Jeong-Joong
Plemper, Richard K.
Liotta, Dennis C.
ACS INFECTIOUS DISEASES, 2020, 6 (05): : 922 - 929
[2] Discovery of novel benzothienoazepine derivatives as potent inhibitors of respiratory syncytial virus
Fordyce, Euan A. F.
Brookes, Daniel W.
Lise-Ciana, Claire
Coates, Matthew S.
Hunt, S. Fraser
Ito, Kazuhiro
King-Underwood, John
Onions, Stuart T.
Parra, Guillaume F.
Rapeport, Garth
Sherbukhin, Vladimir
Stockwell, Jennifer A.
Strong, Peter
Thomas, Jennifer C.
Murray, John
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2017, 27 (10) : 2201 - 2206
[3] Discovery of Piperazinylquinoline Derivatives as Novel Respiratory Syncytial Virus Fusion Inhibitors
Zheng, Xiufang
Wang, Lisha
Wang, Baoxia
Miao, Kun
Xiang, Kunlun
Feng, Song
Gao, Lu
Shen, Hong C.
Yun, Hongying
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (06): : 558 - 562
[4] Discovery of Benzoazepinequinoline (BAQ) Derivatives as Novel, Potent, Orally Bioavailable Respiratory Syncytial Virus Fusion Inhibitors
Zheng, Xiufang
Liang, Chungen
Wang, Lisha
Wang, Baoxia
Liu, Yongfu
Feng, Song
Wu, Jim Zhen
Gao, Lu
Feng, Lichun
Chen, Li
Guo, Tao
Shen, Hong C.
Yun, Hongying
JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (22) : 10228 - 10241
[5] Discovery of (aza)indole derivatives as novel respiratory syncytial virus fusion inhibitors
Zheng, Xiufang
Liang, Chungen
Wang, Lisha
Miao, Kun
Wang, Baoxia
Zhang, Weixing
Chen, Dongdong
Wu, Guolong
Zhu, Wei
Guo, Lei
Feng, Song
Gao, Lu
Shen, Hong C.
Yun, Hongying
MEDCHEMCOMM, 2019, 10 (06) : 970 - 973
[6] Discovery of methylsulfonyl indazoles as potent and orally active respiratory syncytial Virus(RSV) fusion inhibitors
Feng, Song
Li, Chao
Chen, Dongdong
Zheng, Xiufang
Yun, Hongying
Gao, Lu
Shen, Hong C.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 138 : 1147 - 1157
[7] Respiratory syncytial virus - the discovery and optimization of orally bioavailable fusion inhibitors
Meanwell, Nicholas A.
Krystal, Mark
DRUGS OF THE FUTURE, 2007, 32 (05) : 441 - 455
[8] Both heptad repeats of human respiratory syncytial virus fusion protein are potent inhibitors of viral fusion
Wang, EX
Sun, X
Qian, Y
Zhao, LQ
Tien, P
Gao, GF
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2003, 302 (03) : 469 - 475
[9] Discovery of N-Containing (-)-Borneol Esters as Respiratory Syncytial Virus Fusion Inhibitors
Sokolova, Anastasiya S.
Yarovaya, Olga I.
Kuzminykh, Lana V.
Shtro, Anna A.
Klabukov, Artem M.
Galochkina, Anastasia V.
Nikolaeva, Yulia V.
Petukhova, Galina D.
Borisevich, Sophia S.
Khamitov, Edward M.
Salakhutdinov, Nariman F.
PHARMACEUTICALS, 2022, 15 (11)
[10] Discovery of Ziresovir as a Potent, Selective, and Orally Bioavailable Respiratory Syncytial Virus Fusion Protein Inhibitor
Zheng, Xiufang
Gao, Lu
Wang, Lisha
Liang, Chungen
Wang, Baoxia
Liu, Yongfu
Feng, Song
Zhang, Bo
Zhou, Mingwei
Yu, Xin
Xiang, Kunlun
Chen, Li
Guo, Tao
Shen, Hong C.
Zou, Gang
Wu, Jim Zhen
Yun, Hongying
JOURNAL OF MEDICINAL CHEMISTRY, 2019, 62 (13) : 6003 - 6014

← 1 2 3 4 5 →